Phase I trial with carboplatin and RAD001 in metastatic breast cancer

被引：0
|
作者：
Eucker, J.
Schwarzlose-Schwarck, S.
Martus, P.
Regierer, A. C.
Schulz, C. O.
Liu, H.
Scholz, C. W.
Schefe, J. H.
Possinger, K.
机构：
[1] Charite, Dept Hematol & Oncol, Berlin, Germany
[2] Charite, Inst Biostat & Clin Epidemiol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11554
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase I study of sorafenib and RAD001 for metastatic clear cell renal cell carcinoma
    Harzstark, A. L.
    Rosenberg, J. E.
    Weinberg, V. K.
    Sun, J.
    Ryan, C. J.
    Lin, A. M.
    Fong, L.
    Brocks, D. R.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Phase I study of sorafenib and RAD001 for metastatic clear cell renal cell carcinoma
    Rosenberg, J. E.
    Weinberg, V. K.
    Claros, C.
    Ryan, C.
    Lin, A. M.
    Fong, L.
    Brocks, D.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer
    Nakabayashi, Mari
    Werner, Lilian
    Courtney, Kevin D.
    Buckle, Geoffrey
    Oh, William K.
    Bubley, Glen J.
    Hayes, Julia H.
    Weckstein, Douglas
    Elfiky, Aymen
    Sims, Danny M.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    [J]. BJU INTERNATIONAL, 2012, 110 (11) : 1729 - 1735
  • [24] PHASE I TRIAL OF RAD001 (EVEROLIMUS) IN COMBINATION WITH RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Deutsch, E.
    Lepechoux, C.
    Pignon, J. P.
    Tao, Y. T.
    Rivera, S.
    Bourgier, B. C.
    Angokai, M.
    Bahleda, R.
    Slimane, K.
    Angevin, E.
    Besse, B. B.
    Soria, J. C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 9 - 9
  • [25] A Phase Ib Trial of RAD001, an mTOR Inhibitor, with Weekly Cisplatin and Paclitaxel in Patients with HER2-Negative Metastatic Breast Cancer.
    Mayer, I. A.
    Burris, H. A.
    Bendell, J. C.
    Means-Powell, J.
    Arteaga, C. L.
    Shyr, Y.
    Pietenpol, J. A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 677S - 677S
  • [26] Phase I trial of patupilone (P) and RAD001 in patients (pts) with advanced solid tumors
    Stein, M. N.
    Knox, B.
    Wesolowsky, E.
    Levitt, M.
    Moss, R.
    Poplin, E.
    Mehnert, J.
    Gounder, M.
    Goodin, S.
    DiPaola, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] A phase I trial of imatinib, hydroxyurea and RAD001 for patients with recurrent malignant glioma.
    Reardon, D.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Desjardins, A.
    Sathornsumetee, S.
    Gururangan, S.
    Egorin, M. J.
    Salvado, A.
    Friedman, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 77S - 77S
  • [28] A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma
    Desjardins, A.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Sathornsumetee, S.
    Gururangan, S.
    Friedman, A. H.
    Berg, W.
    Egorin, M. J.
    Salvado, A.
    Friedman, H. S.
    Reardon, D. A.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 441 - 441
  • [29] Phase I study of RAD001 (everolimus), cetuximab, and irinotecan as second-line therapy in metastatic colorectal cancer (mCRC)
    Sharma, S.
    Reid, T.
    Hoosen, S.
    Garrett, C.
    Beck, J.
    Davidson, S.
    MacKenzie, M.
    Brandt, U.
    Hecht, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab
    Jerusalem, G. H.
    Dieras, V.
    Cardoso, F.
    Bergh, J.
    Fasolo, A.
    Rorive, A.
    Manlius, C.
    Pylvaenaeinen, I.
    Sahmoud, T.
    Gianni, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345